<DOC>
	<DOCNO>NCT00169845</DOCNO>
	<brief_summary>Epidemiologic study suggest low dietary intake low plasma concentration antioxidant vitamin mineral associate increased risk cancer , especially epidermoid tumor . Patients stage I II head neck cancer good prognosis , 5-year relative survival 60 % 90 % , depend tumor site . However , benefit treatment often compromise occurrence second primary cancer , develop 20 % patient first 5 year diagnosis . We conduct randomized chemoprevention trial among patient head neck cancer treat radiation therapy determine whether supplementation combine two antioxidant , alpha-tocopherol beta-carotene , could reduce incidence second primary cancer patient population ( primary objective trial ) . This study conduct fund NCIC ( # 008176,004738,013211 ) complete . In cohort head neck cancer patient , evaluate whether nine potential prognostic serum marker measure time diagnosis relate recurrence , occurence second primary cancer survival . This study conduct fund NCIC ( # 018100 ) complete . Presently , evaluate genetic polymorphism ( GWAS ) associate prognosis ( NCIC grant # 019502 ) . We also assess relationship vitamin D ( dietary intake , serum level , genetic polymorphism key vitamin D-related gene ) head neck long-term outcome ( NCI grant # 1R03CA141615-01 ) .</brief_summary>
	<brief_title>Beta-carotene Alpha-tocopherol Chemoprevention Second Primary Malignancies Head Neck Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<mesh_term>Beta Carotene</mesh_term>
	<criteria>Histologically document stage I II head neck cancer Karnofsky performance score le 60 Multiple primary head neck cancer History cancer Severe cardiovascular disease Inadequate renal , hepatic hematologic function Anticoagulant therapy Pregnancy Average daily supplement intake betacarotene vitamin E precede year great 6.0 mg 50 IU , respectively .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>chemoprevention trial</keyword>
	<keyword>antioxidant</keyword>
	<keyword>alpha-tocopherol</keyword>
	<keyword>beta-carotene</keyword>
	<keyword>second primary cancer</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>adverse effect radiation therapy</keyword>
	<keyword>quality life</keyword>
	<keyword>mortality</keyword>
	<keyword>cancer free survival</keyword>
	<keyword>cancer recurrence</keyword>
</DOC>